New Frontiers in Cancer: From The Tumor Microenvironment to CARs

Tuesday, May 12, 2026

12:05 PM - 12:50 PM ET

Co-Moderator(s)

Karin Hardiman, MD, Ph.D (she/her/hers)

Professor
University of Alabama at Birmingham
University of Alabama at Birmingham
Birmingham, AL, United States

Disclosure information not submitted.
J. Joshua Smith, MD, PhD

Professor and Chair, Colon and Rectal Surgery Department
MD Anderson Cancer Center
MD Anderson Cancer Center
Houston, TX, United States

Disclosure information not submitted.

CME .75 hours

This symposium will explore key factors influencing treatment response in colorectal cancer. Participants will review potential reasons for treatment resistance, including tumor biology and patient-specific considerations. The discussion will also examine the role of the tumor microenvironment in shaping therapeutic outcomes. In addition, emerging and novel immunotherapy approaches will be highlighted, with a focus on their evolving role in the management of colorectal cancer.

Learning Objectives:

Upon completion of this activity, participants should be able to:

Describe potential reasons for treatment resistance in colorectal cancer.
Explain potential factors in the tumor microenvironment that are important in treatment response.
Recognize novel immunotherapies to treat colorectal cancer.